×
About 23,022 results

ALLMedicine Hypoglycemia Center

Research & Reviews  10,305 results

Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients.
https://doi.org/10.1080/08037051.2020.1770054
Blood Pressure; Błaszkowska M, Shalimova A et. al.

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

Glucose Homeostasis and the Neonatal Brain: A Sweet Relationship.
https://doi.org/10.1891/0730-0832.39.3.137
Neonatal Network : NN; Amendoeira S, McNair C et. al.

May 26th, 2020 - Glucose is the primary substrate for energy metabolism in the brain and although the brain is dependent on a constant glucose supply for normal function, both local energy stores and the supply of alternate substrates are limited. In utero, the pl...

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
https://doi.org/10.1210/endrev/bnaa017
Endocrine Reviews; Galindo RJ, Beck RW et. al.

May 26th, 2020 - Glucose and insulin metabolism in patients with diabetes are profoundly altered by advanced chronic kidney disease. Risk of hypoglycemia is increased by failure of kidney gluconeogenesis, impaired insulin clearance by the kidney, defective insulin...

Report: central diabetes insipidus and schwannoma in a male with X-linked congenital ad...
https://doi.org/10.1186/s12902-020-00553-0
BMC Endocrine Disorders; Seo BK, Jeong SA et. al.

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Ad...
https://doi.org/10.2337/dc20-0016
Diabetes Care; Toschi E, Slyne C et. al.

May 26th, 2020 - Continuous glucose monitoring (CGM) is now commonly used in the management of type 1 diabetes (T1D). The CGM-derived coefficient of variation (CV) measures glucose variability, and the glucose management indicator (GMI) measures mean glycemia (pre...

see more →

Guidelines  45 results

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
https://www.nejm.org/doi/full/10.1056/NEJMoa1911303
The New England Journal of Medicine; McMurray,J.,et al

Sep 18th, 2019 - BACKGROUND In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the eff...

Xeris Pharmaceuticals Receives U.S. Fda Approval For Gvoke™ (Glucagon), The First Ready-to-use Stable Liquid Glucagon For Severe Hypoglycemia
https://xerispharma.gcs-web.com/news-releases/news-release-details/xeris-pharmaceuticals-receives-us-fda-approval-gvoketm-glucagon

Sep 9th, 2019 - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received reg...

BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
https://investor.lilly.com/news-releases/news-release-details/baqsimitm-glucagon-nasal-powder-3-mg-first-and-only-nasally

Jul 23rd, 2019 - The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above, Eli Lilly and Company (NYSE: LLY) announced today. BAQSIMI i...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British...
https://doi.org/10.1177/0890334419846128
Journal of Human Lactation : Official Journal of International Lactation Consultant Association; Hawdon JM

May 5th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

see more →

Drugs  87 results see all →

Clinicaltrials.gov  11,253 results

Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients.
https://doi.org/10.1080/08037051.2020.1770054
Blood Pressure; Błaszkowska M, Shalimova A et. al.

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

Glucose Homeostasis and the Neonatal Brain: A Sweet Relationship.
https://doi.org/10.1891/0730-0832.39.3.137
Neonatal Network : NN; Amendoeira S, McNair C et. al.

May 26th, 2020 - Glucose is the primary substrate for energy metabolism in the brain and although the brain is dependent on a constant glucose supply for normal function, both local energy stores and the supply of alternate substrates are limited. In utero, the pl...

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
https://doi.org/10.1210/endrev/bnaa017
Endocrine Reviews; Galindo RJ, Beck RW et. al.

May 26th, 2020 - Glucose and insulin metabolism in patients with diabetes are profoundly altered by advanced chronic kidney disease. Risk of hypoglycemia is increased by failure of kidney gluconeogenesis, impaired insulin clearance by the kidney, defective insulin...

Report: central diabetes insipidus and schwannoma in a male with X-linked congenital ad...
https://doi.org/10.1186/s12902-020-00553-0
BMC Endocrine Disorders; Seo BK, Jeong SA et. al.

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Ad...
https://doi.org/10.2337/dc20-0016
Diabetes Care; Toschi E, Slyne C et. al.

May 26th, 2020 - Continuous glucose monitoring (CGM) is now commonly used in the management of type 1 diabetes (T1D). The CGM-derived coefficient of variation (CV) measures glucose variability, and the glucose management indicator (GMI) measures mean glycemia (pre...

see more →

News  1,285 results

Smoking, hypoglycemia, kidney function tied to vision loss in type 2 diabetes
https://www.mdedge.com/familymedicine/article/219004/diabetes/smoking-hypoglycemia-kidney-function-tied-vision-loss-type-2?channel=255
MDedge Endocrinology; Steve Cimino

Mar 13th, 2020 - Several risk factors, including smoking, a previous severe hypoglycemic event, and poorly functioning kidneys, can lead to vision loss in patients with type 2 diabetes, according to new findings published in the Journal of Diabetes and its Complic.

NPH insulin: It remains a good option
https://www.mdedge.com/clinicianreviews/article/218305/diabetes/nph-insulin-it-remains-good-option/page/0/1?channel=205

Mar 3rd, 2020 - Per 1000 person-years, there was no significant difference in hypoglycemia-related ED visits or hospital admissions between the analog and NPH groups (11. 9 events vs 8.

'Striking Paradox' of Misaligned Diabetes Treatment Could Harm
https://www.medscape.com/viewarticle/925448

Feb 18th, 2020 - Older patients with diabetes and multiple comorbidities were more likely to be treated to a lower A1c level with insulin — exposing them to the risk of hypoglycemia — whereas younger healthier patients who could benefit from more aggressive therap...

Less gestational weight gain seen with metformin
https://www.mdedge.com/clinicianreviews/article/216914/obstetrics/less-gestational-weight-gain-seen-metformin?channel=53
Kari Oakes

Feb 7th, 2020 - GRAPEVINE, TEX. * – Pregnant women with type 2 diabetes or prediabetes had significantly less gestational weight gain if they had metformin exposure at any point in their pregnancies, with no differences in infant birth weight or postnatal infant h.

Transitions To, From Insulin Degludec Require Careful Follow-Up
https://www.medscape.com/viewarticle/923335

Jan 5th, 2020 - NEW YORK (Reuters Health) - Transitions of patients to and from insulin degludec require close follow-up, including frequent adjustments of insulin doses, to avoid potential hypoglycemia, according to a new report. "One can induce stacking of basa...

see more →

Patient Education  47 results see all →